Skip to main content
. 2021 Apr 30;2021(4):CD013257. doi: 10.1002/14651858.CD013257.pub3

1.22. Analysis.

1.22

Comparison 1: Single immunecheckpoint inhibitors vs chemotherapy, Outcome 22: HRQoL‐QLQC30‐change from baseline at week 15 ‐improvement ‐ PD‐L1≥50%